Exendin (9-39) is a competitive GLP-1 (glucagon-like peptide 1) receptor antagonist. Exendin (9-39) blocks the stimulatory action of GLP-1 amide, exendin-3 and exendin-4 on cAMP production in pancreatic acini. In addition, exendin (9-39) was showed not to interfer the insulin normal secretion.
CAT No: 10-101-83
CAS No:133514-43-9 (net)
Synonyms/Alias:Ex4 peptide; Exendin9-39
1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.